经蝶垂体手术后早期术后MRI与残留腺瘤的检测
本研究纳入102例连续接受显微镜下经蝶垂体腺瘤切除术的成人患者,比较术后48小时内早期MRI、术者术中评估与术后3个月晚期MRI对残留腺瘤的检测效能。早期MRI的读者间信度几乎完美(κ=0.88),敏感度100%、特异度98%,均优于术中评估和晚期MRI。结论认为早期MRI可靠且敏感度更高,挑战了现行指南中延迟影像优先于早期影像的观点。
要点
- 早期MRI检测残留腺瘤的读者间信度几乎完美(κ=0.88),显著高于晚期MRI(κ=0.69,p=0.03)。
- 早期MRI敏感度100%,显著高于术中评估(78%,p=0.04)和晚期MRI(78%,p=0.04)。
- 早期MRI特异度98%,与术中评估(99%,p=0.60)相似,显著高于晚期MRI(81%,p<0.001)。
核心结论
- 经蝶垂体手术后早期MRI可可靠判读,检测残留肿瘤的敏感度高于术中评估和晚期MRI。
- 该结果挑战了现行指南中延迟术后影像优于早期影像的观点,垂体外科医生应考虑行早期MRI以补充或替代延迟影像。
研究设计与样本
- 纳入接受显微镜下经蝶垂体腺瘤手术的成人患者,术前、术后48小时内、术后3个月及每年至4年均行MRI。
- 共纳入102例连续患者,由单一位术者术中评估残留肿瘤,由2名对术中评估和其他术后影像不知情的神经放射科医生术后判读。
- 残留肿瘤通过再次切除、影像学肿瘤生长或激素证据确认,并计算各时间点影像的读者间信度及诊断效能。
主要发现
- 18例患者(18%)确认有残留肿瘤,其中12例由肿瘤生长确认、5例由手术确认、1例由持续疾病的生化证据确认。
- 早期MRI检测残留肿瘤的读者间信度几乎完美(κ=0.88),显著高于晚期MRI(κ=0.69,p=0.03)。
- 早期MRI特异度为98%,与术中评估(99%,p=0.60)相似,显著高于晚期MRI(81%,p<0.001)。
- 早期MRI敏感度为100%,显著高于术中评估(78%,p=0.04)和晚期MRI(78%,p=0.04)。
- 早期MRI阴性预测值为100%,并发现4例术中未识别的残留肿瘤;早期MRI发现的残留肿瘤使3例患者在同一次住院期间接受再次切除。
关键数值与推荐
- 早期MRI检测残留肿瘤的读者间信度κ=0.88,晚期MRI为κ=0.69(p=0.03)。
- 早期MRI敏感度100%,术中评估78%(p=0.04),晚期MRI 78%(p=0.04)。
- 早期MRI特异度98%,术中评估99%(p=0.60),晚期MRI 81%(p<0.001)。
- 早期MRI阴性预测值100%。
临床怎么用
- 作者认为,经蝶垂体手术后早期MRI可可靠判读,检测残留肿瘤的敏感度高于术中评估和晚期MRI。
- 作者建议,垂体外科医生应考虑行早期MRI以补充或替代延迟影像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current practice guidelines recommend delayed (≥ 3 months after operation) postoperative MRI after transsphenoidal surgery for pituitary adenomas, although this practice defers obtaining important information, such as the presence of a residual adenoma, that might influence patient management during the perioperative period. In this study, the authors compared detection of residual adenomas by means of early postoperative (EPO) MRI (< 48 hours postsurgery) with both surgeon intraoperative assessment and late postoperative (LPO) MRI at 3 months. METHODS: Adult patients who underwent microscopic transsphenoidal surgery for pituitary adenomas with MRI preoperatively, < 48 hours after the operation, 3 months postoperatively, and yearly for 4 years were included. The presence or absence of residual tumor was assessed intraoperatively by a single surgeon and postoperatively by 2 neuroradiologists blinded to the intraoperative assessment and other postoperative imaging studies. The presence of residual tumor was confirmed by reresection, tumor growth on imaging, or hormonal evidence. Interreader reliability was calculated at each imaging time point. Specificity, sensitivity, positive predictive value, and negative predictive value for EPO and LPO imaging and intraoperative assessment were determined. RESULTS: In total, 102 consecutive patients who underwent microscopic transsphenoidal resection of a pituitary adenoma were included. Eighteen patients (18%) had confirmed residual tumors (12 confirmed by tumor growth, 5 by surgery, and 1 by biochemical evidence of persistent disease). Interreader reliability for detecting residual tumor on EPO MRI was almost perfect (κ = 0.88) and significantly higher than that for LPO MRI (κ = 0.69, p = 0.03). EPO MRI was highly specific for residual tumor (98%), a finding similar to that for intraoperative assessment (99%, p = 0.60) and significantly higher than that for LPO MRI (81%, p < 0.001). Notably, EPO MRI was significantly more sensitive for residual tumor (100%) than both intraoperative assessment (78%, p = 0.04) and LPO MRI (78%, p = 0.04). EPO MRI had a 100% negative predictive value and was used to find 4 residual tumors that were not identified intraoperatively. Residual tumors found on EPO MRI allowed for reresection during the same hospitalization for 3 patients. CONCLUSIONS: EPO MRI after transsphenoidal pituitary surgery can be reliably interpreted and has greater sensitivity for detecting residual tumor than intraoperative assessment and LPO MRI. This result challenges current guidelines stating that delayed postoperative imaging is preferable to early imaging. Pituitary surgeons should consider performing EPO MRI either in addition to or instead of delayed imaging.
引用
- Alhilali LM, Little AS, Yuen KCJ, et al. Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery. J Neurosurg. 2020. PMID: 32032952. doi:10.3171/2019.11.JNS191845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。